GeneDx Holdings Corp.
WGS
$85.74
-$5.87-6.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -220.06% | 165.42% | 71.51% | -44.14% | 21.47% |
| Total Depreciation and Amortization | 21.90% | -21.44% | 13.63% | -0.57% | 1,137.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 239.22% | -247.46% | -83.73% | 267.31% | 186.54% |
| Change in Net Operating Assets | 143.18% | -34.88% | -62.22% | 53.83% | 8.14% |
| Cash from Operations | 419.89% | 27.58% | 2.44% | 72.55% | 45.03% |
| Capital Expenditure | -100.95% | -372.14% | 52.22% | -205.19% | 81.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -229.55% | 135.60% | 66.70% | -1,760.11% | 148.80% |
| Cash from Investing | -1,712.72% | 93.31% | 65.84% | -2,792.88% | 117.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 40.38% | -116.12% | -33.90% | -14.29% | 68.46% |
| Issuance of Common Stock | -55.06% | 121.81% | 10,611.68% | 470.83% | 26.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -55.78% | 122.10% | 3,672.38% | 10.73% | -100.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.96% | 1,402.81% | 106.59% | -72.40% | -229.29% |